Details of the Drug

General Information of Drug (ID: DMXN2ZQ)

Drug Name
IMO-2134
Indication
Disease Entry ICD 11 Status REF
Allergy 4A80-4A85 Preclinical [1]
Asthma CA23 Preclinical [1]
Cross-matching ID
TTD ID
D02ZWR
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Toll-like receptor 9 (TLR9) TTSHG0T TLR9_HUMAN Agonist [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Allergy
ICD Disease Classification 4A80-4A85
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Toll-like receptor 9 (TLR9) DTT TLR9 4.48E-03 -0.52 -2.31
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Idera Pharmaceuticals (2011).